Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15176 - 15200 of 15218 in total

7-Nitroindazole-2-Carboxamidine

Experimental

5-Nitroindazole

Experimental

2-[1-METHYLHEXYL]-4,6-DINITROPHENOL

Experimental

FavId

FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
Investigational

R-348

Investigational

Vestipitant

Vestipitant has been investigated for the treatment of Tinnitus.
Investigational

(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium

Experimental

KB002

KB002 is an engineered human IgG1k antibody engineered human. It is developed for the treatment of autoimmune diseases, initially rheumatoid arthritis.
Investigational

P-Nitrophenol

Experimental

3-(4-nitrophenyl)-1H-pyrazole

Experimental

Tozadenant

Tozadenant has been investigated for the basic science of Cocaine Dependence.
Investigational

(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine

Experimental

Trifluperidol

Experimental

Dihydroquinidine barbiturate

Experimental

ISIS 113715

ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose control along with statistically significant reductions in LDL-cholesterol.
Investigational

RG-7795

Investigational

4-Nitrocatechol

Experimental

VLTS-589

VLTS-589 consists of plasmid encoding the angiomatrix protein Del-1 in conjunction with poloxamer 188 for the treatment of peripheral vascular disease.
Investigational

3,5-Dinitrocatechol

Experimental

Pyrrolnitrin

Experimental

Etonitazene

Experimental
Illicit

Plinabulin

Investigational

BTA9881

BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials.
Investigational

Alamifovir

Alamifovir is an antiviral agent specific for HBV.
Investigational

CHGN111

CHGN111 is an inhibitor of the mitochondrial enzyme CLK-1 which is a demethoxyubiquinone hydroxylase. Numerous parameters of mitochondrial function are altered when the activity of CLK-1 is reduced, which results in a decrease of ROS at critical cellular sites, as well as in a decrease of systemic oxidative stress. It...
Investigational
Displaying drugs 15176 - 15200 of 15218 in total